Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clare Allen

Showing results (71-80 of 127) with videos related to

Pageof 13
Sort By:
BJU International|September 14, 2013
TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancerAbdel-Rahmène Azzouzi, Eric Barret, Caroline M Moore, et al.
Magnetic Resonance Imaging|January 4, 2020
DWI and PRECISE criteria in men on active surveillance for prostate cancer: A multicentre preliminary experience of different ADC calculationsFrancesco Giganti, Martina Pecoraro, Davide Fierro, et al.
BMJ Open|January 30, 2020
Genetic landscape of prostate cancer conspicuity on multiparametric MRI: a protocol for a systematic review and bioinformatic analysisJoseph M Norris, Benjamin S Simpson, Marina A Parry, et al.
BJU International|October 11, 2019
Genetic correlates of prostate cancer visibility (and invisibility) on multiparametric magnetic resonance imaging: it's time to take stockJoseph M Norris, Benjamin S Simpson, Marina A Parry, et al.
BMJ Open|October 5, 2018
Can the completeness of radiological cancer staging reports be improved using proforma reporting? A prospective multicentre non-blinded interventional study across 21 centres in the UKAnisha Patel, Andrea Rockall, Ashley Guthrie, et al.
European Radiology|December 18, 2019
Interobserver reproducibility of the PRECISE scoring system for prostate MRI on active surveillance: results from a two-centre pilot studyFrancesco Giganti, Martina Pecoraro, Vasilis Stavrinides, et al.
BJU International|April 23, 2020
Prostate cancer visibility on multiparametric magnetic resonance imaging: high Gleason grade and increased tumour volume are not the only important histopathological featuresJoseph M Norris, Lina M Carmona Echeverria, Benjamin S Simpson, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 7, 2023
Picture Perfect: The Status of Image Quality in Prostate MRIAlexandre Woernle, Cameron Englman, Louise Dickinson, et al.
The British Journal of Radiology|September 21, 2020
Prostate cancer measurements on serial MRI during active surveillance: it's time to be PRECISEFrancesco Giganti, Vasilis Stavrinides, Armando Stabile, et al.
The Journal of Urology|October 16, 2012
Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancerVeeru Kasivisvanathan, Robert Dufour, Caroline M Moore, et al.
Pageof 13

Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
BJU International|September 14, 2013
TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancerAbdel-Rahmène Azzouzi, Eric Barret, Caroline M Moore, et al.
Magnetic Resonance Imaging|January 4, 2020
DWI and PRECISE criteria in men on active surveillance for prostate cancer: A multicentre preliminary experience of different ADC calculationsFrancesco Giganti, Martina Pecoraro, Davide Fierro, et al.
BMJ Open|January 30, 2020
Genetic landscape of prostate cancer conspicuity on multiparametric MRI: a protocol for a systematic review and bioinformatic analysisJoseph M Norris, Benjamin S Simpson, Marina A Parry, et al.
BJU International|October 11, 2019
Genetic correlates of prostate cancer visibility (and invisibility) on multiparametric magnetic resonance imaging: it's time to take stockJoseph M Norris, Benjamin S Simpson, Marina A Parry, et al.
BMJ Open|October 5, 2018
Can the completeness of radiological cancer staging reports be improved using proforma reporting? A prospective multicentre non-blinded interventional study across 21 centres in the UKAnisha Patel, Andrea Rockall, Ashley Guthrie, et al.
European Radiology|December 18, 2019
Interobserver reproducibility of the PRECISE scoring system for prostate MRI on active surveillance: results from a two-centre pilot studyFrancesco Giganti, Martina Pecoraro, Vasilis Stavrinides, et al.
BJU International|April 23, 2020
Prostate cancer visibility on multiparametric magnetic resonance imaging: high Gleason grade and increased tumour volume are not the only important histopathological featuresJoseph M Norris, Lina M Carmona Echeverria, Benjamin S Simpson, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 7, 2023
Picture Perfect: The Status of Image Quality in Prostate MRIAlexandre Woernle, Cameron Englman, Louise Dickinson, et al.
The British Journal of Radiology|September 21, 2020
Prostate cancer measurements on serial MRI during active surveillance: it's time to be PRECISEFrancesco Giganti, Vasilis Stavrinides, Armando Stabile, et al.
The Journal of Urology|October 16, 2012
Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancerVeeru Kasivisvanathan, Robert Dufour, Caroline M Moore, et al.
Pageof 13